Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ICML 2021 | FOLL12: standard vs response adapted maintenance in FL

Stefano Luminari • 23 Jun 2021
ICML 2021
Follicular Lymphoma Lymphoma Non-Hodgkin Lymphoma Antibodies R-CHOP Rituximab
FOLL12

Stefano Luminari, MD, University of Modena and Reggio Emilia, Emilia-Romagna, Italy, summarizes the results of the Phase III FOLL12 trial (NCT02063685) assessing response adapted maintenance in patients with follicular lymphoma. All patients received induction immunochemotherapy and patients in the standard arm received rituximab, whereas patients in the experimental arm received differing treatments depending on their metabolic and molecular response. Patients receiving response adapted maintenance had inferior responses in terms of progression-free survival. This interview took place during the 2021 International Conference on Malignant Lymphoma (16-ICML).

More from Stefano Luminari

2:14
Long-term follow-up results from the RATHL trial: response-adapted treatment for advanced stage HL
Stefano Luminari • 12 Dec 2022
2:23
Results from the Phase II ELM-2 trial: odronextamab for R/R follicular lymphoma
Stefano Luminari • 12 Dec 2022
2:29
Independent prognostic value of total metabolic tumor volume in advanced-stage FL
Stefano Luminari • 12 Dec 2022
1:46
R-CHOP versus R-bendamustine in FL
Stefano Luminari • 12 Dec 2021

Related Videos

1:32
Promising novel immunotherapeutic approaches in lymphoma
Gloria Iacoboni • 15 Apr 2024
3:03
AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study
Jacopo Mariotti • 15 Apr 2024
2:28
Checkpoint inhibitors vs brentuximab vedotin as salvage therapy prior to alloSCT for HL
Jacopo Mariotti • 15 Apr 2024
1:37
Exciting CAR-T clinical trials in LBCL and FL
Gloria Iacoboni • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals